US startup investors — January 2026 · Jan 1, 2026 – Jan 31, 2026
Recent funding activity in US startups, organised by investor and their role in each round.
Browse by month
Details
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Heritable Agriculture $5M GrantQure.ai Undisclosed GrantDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Cellares $257M Series DNeurophos $110M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Eliyan Corporation $50M StrategicUpscale AI $200M Series ADetails
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Gyde $60M UndisclosedCambium $100M Series BDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Oro $3M UndisclosedAtomic Insights $10M SeedDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Checkbox $23M Series AClaim Health $4.4M SeedDetails
New companies 2 · Follow-on 0
Stages: Series A 2
Slice Global Equity $25M Series AConverge Bio $25M Series ADetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Cellares $257M Series DMirador Therapeutics $250M Series BDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Gyde $60M UndisclosedPrudentia Sciences $20M Series ADetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Cellares $257M Series DKinaset Therapeutics $103M Series BDetails
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
TRex Bio $50M UndisclosedEpiBiologics $107M Series BDetails
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
TRex Bio $50M UndisclosedSTRM.BIO $8M Seed2Details
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
TRex Bio $50M UndisclosedJuvena Therapeutics $33.5M Series BDetails
Details
Details
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
TRex Bio $50M UndisclosedEpiBiologics $107M Series BDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
FLORA $42M Series ALiveKit $100M Series CDetails
Details
New companies 2 · Follow-on 0
Stages: Undisclosed 2
TRex Bio $50M UndisclosedPayMedix $33M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Grid Aero $20M Series AJuvena Therapeutics $33.5M Series BDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Upwind Security $250M Series BOpenEvidence $250M Series DDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Upwind Security $250M Series BCyera $400M Series FDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Ricursive Intelligence $300M Series AOpenEvidence $250M Series DDetails
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Upwind Security $250M Series BBaseten $300M Series EDetails
“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.